GENE EXPRESSION MARKERS FOR RESPONSE TO EGFR INHIBITOR DRUGS
摘要
The present invention concerns prognostic markers associated with cancer. In particular, the invention concerns prognostic methods based on the molecular characterization of gene expression in paraffin-embedded, fixed samples of cancer tissue, which allow a physician to predict whether a patient is likely to respond well to treatment with an EGFR inhibitor.
申请公布号
WO2004111273(A2)
申请公布日期
2004.12.23
申请号
WO2004US17215
申请日期
2004.05.28
申请人
GENOMIC HEALTH, INC.;AGUS, DAVID;BAKER, JOFFRE, B.;NATALE, RONALD;SHAK, STEVEN
发明人
AGUS, DAVID;BAKER, JOFFRE, B.;NATALE, RONALD;SHAK, STEVEN